Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company > Summary
Court Case Number 1:18-cv-10242
Filing Date Feb 6, 2018
Termination Date Sep 27, 2018
Court Massachusetts District Court
Status Dismissed - Other
JudgesAllison D. Burroughs
Defendant
Plaintiff Attorneys
5Teva Pharmaceuticals
Attorney Name: Elaine H. Blais
Goodwin Procter LLP
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Douglas John Kline
Goodwin Procter LLP
Teva Pharmaceuticals
Attorney Name: Douglas John Kline
Goodwin Procter LLP
Teva Pharmaceuticals
Attorney Name: Neel Chatterjee
Goodwin Procter LLP
Defendant Attorneys
5Eli Lilly and Company
Attorney Name: Danielle A. Duszczyszyn
Finnegan, Henderson, Farabow, Garrett & Dunner
Eli Lilly and Company
Attorney Name: Emily R. Gabranski
Finnegan, Henderson, Farabow, Garrett & Dunner
Eli Lilly and Company
Attorney Name: Charles E. Lipsey
Finnegan, Henderson, Farabow, Garrett & Dunner
Eli Lilly and Company
Attorney Name: Andrea L. Martin
Burns & Levinson
Eli Lilly and Company
Attorney Name: William B. Raich
Finnegan, Henderson, Farabow, Garrett & Dunner
Cause
28:2201 Declaratory Judgment
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09890210 | Antagonist antibodies directed against calcitonin gene-related peptide | Feb 13, 2018 |
| 09890211 | Antagonist antibodies directed against calcitonin gene-related peptide | Feb 13, 2018 |
| 09884907 | Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide | Feb 6, 2018 |
| 09884908 | Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide | Feb 6, 2018 |
